Xiaoqing Cai
132 East Outer Ring Road
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity.
Journal: ACS chemical biology
Published: April 01, 2026
Integrated bioinformatics and mendelian randomization reveal a six-gene diagnostic signature and key role of CYP26B1 in sarcopenia.
Journal: Frontiers in molecular biosciences
Published: December 04, 2025
Global Research Landscape in T Cells and Myasthenia Gravis: Trends, Collaborations, and Future Directions.
Journal: Molecular neurobiology
Published: July 09, 2025
Targeting mitochondrial quality control: Ginsenoside Rg1 as a therapeutic candidate for neuromuscular diseases.
Journal: Journal of ginseng research
Published: April 22, 2025
Development of Antibody-Based Strategies for Targeted Degradation of Membrane and Extracellular Proteins.
Journal: Chembiochem : a European journal of chemical biology
Published: February 27, 2025
Glucose Transporter-Targeting Chimeras Enabling Tumor-Selective Degradation of Secreted and Membrane Proteins.
Journal: ACS chemical biology
Published: October 07, 2024
Harnessing molecular probes for imaging of human epidermal growth factor receptor (HER) family.
Journal: Bioorganic & medicinal chemistry
Published: August 18, 2024
Lysosome-targeting chimeras containing an endocytic signaling motif trigger endocytosis and lysosomal degradation of cell-surface proteins.
Journal: Chemical science
Published: July 30, 2024
Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and Fibrosis.
Journal: Journal of medicinal chemistry
Published: July 11, 2024
Editorial: Cancer treatment and early detection targeting HER receptors, Volume II.
Journal: Frontiers in molecular biosciences
Published: May 27, 2023
Design and Discovery of Novel Cyclic Peptides as EDPs-EBP Interaction Inhibitors for the Treatment of Liver Fibrosis.
Journal: Journal of medicinal chemistry
Published: March 20, 2023
Last Updated: 09/26/2026